{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-051532","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.209910+00:00","generated_at":"2026-05-24T23:56:19.175015+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xilio Therapeutics enters into $50M ATM equity offering with Leerink Partners","bullets":["Xilio entered into Sales Agreement with Leerink Partners to sell up to $50M of common stock via ATM offering.","Agent Leerink will receive 3.0% commission on gross proceeds from any shares sold under the agreement.","Sales will be made on Nasdaq Global Select Market under effective S-3 registration statement filed Nov 2022.","No minimum sales obligation; company retains discretion over timing and amount of any sales.","The ATM facility was established on March 11, 2025; either party may terminate upon written notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-051532","json":"https://secwatch.observer/filing/0001193125-25-051532.json","markdown":"https://secwatch.observer/filing/0001193125-25-051532.md","text":"https://secwatch.observer/filing/0001193125-25-051532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000119312525051532/0001193125-25-051532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000119312525051532/d897420d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:56:19.175015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}